Effects of personality on the association between paroxetine plasma concentration and response

Código QR

Effects of personality on the association between paroxetine plasma concentration and response

Tetsu Tomita,1 Norio Yasui-Furukori,1 Taku Nakagami,2 Shoko Tsuchimine,3 Masamichi Ishioka,4 Ayako Kaneda,1 Kazuhiko Nakamura1 1Department of Neuropsychiatry, Graduate School of Medicine, Hirosaki University, Hirosaki, Japan; 2Department of Psychiatry, Nakagami Mental Clinic, Odate, Japan; 3Departm...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Tomita T, Yasui-Furukori N, Nakagami T, Tsuchimine S, Ishioka M, Kaneda A, Nakamura K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2018
Materias:	depression paroxetine concentration personality Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/55f70432ff5f4148885d2d0670e2a68d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Adding metoclopramide to paroxetine induced extrapyramidal symptoms and hyperprolactinemia in a depressed woman: a case report
por: Igata R, et al.
Publicado: (2016)

Escitalopram versus paroxetine controlled release in major depressive disorder: a randomized trial
por: Kishi T, et al.
Publicado: (2017)

Sex differences in the prediction of the effectiveness of paroxetine for patients with major depressive disorder identified using a receiver operating characteristic curve analysis for early response [Corrigendum]
por: Tomita T, et al.
Publicado: (2014)

Comparative effectiveness of switching paroxetine formulation for treatment of major depressive disorder: an open-label multicenter study
por: Otsubo T, et al.
Publicado: (2018)

Agomelatine versus paroxetine in treating depressive and anxiety symptoms in patients with chronic kidney disease
por: Chen JW, et al.
Publicado: (2018)

Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction
por: Tian XQ, et al.
Publicado: (2016)

Factors affecting discontinuation of initial treatment with paroxetine in panic disorder and major depressive disorder
por: Aoki A, et al.
Publicado: (2014)

Timing of psychoeducation for patients with depression who were treated with antidepressants: when should patients receive psychoeducation
por: Tomita T, et al.
Publicado: (2018)

The low level of understanding of depression among patients treated with antidepressants: a survey of 424 outpatients in Japan
por: Kudo S, et al.
Publicado: (2015)

The influence of 5-HTTLPR genotype on the association between the plasma concentration and therapeutic effect of paroxetine in patients with major depressive disorder.
por: Tetsu Tomita, et al.
Publicado: (2014)

Sex Differences In Psychoeducation For Patients With Depression: A Comparison Of Frequency And Efficacy Of Psychoeducation
por: Tomita T, et al.
Publicado: (2019)

A positive correlation between serum amyloid β levels and depressive symptoms among community-dwelling elderly individuals in Japan
por: Tsuruga K, et al.
Publicado: (2014)

The characteristics of understanding of depression among older patients treated with antidepressants: a comparison between older and younger patients
por: Tomita T, et al.
Publicado: (2018)

Hyperprolactinemia during antipsychotics treatment increases the level of coagulation markers
por: Ishioka M, et al.
Publicado: (2015)

Work–family conflict as a mediator between occupational stress and psychological health among mental health nurses in Japan
por: Sugawara N, et al.
Publicado: (2017)

The effects of additional treatment with terguride, a partial dopamine agonist, on hyperprolactinemia induced by antipsychotics in schizophrenia patients: a preliminary study
por: Hashimoto K, et al.
Publicado: (2014)

The Yamaguchi fox/pigeon-imitation test, a brief cognitive performance rating tool, in a community-dwelling population: normative data for Japanese subjects – a preliminary study
por: Ishioka M, et al.
Publicado: (2014)

Personality associated with depressive status in individuals with type 2 diabetes mellitus
por: Yasui-Furukori N, et al.
Publicado: (2019)

Application of a stratum-specific likelihood ratio analysis in a screen for depression among a community-dwelling population in Japan
por: Sugawara N, et al.
Publicado: (2017)

Prevalence of major depressive disorder among hemodialysis patients compared with healthy people in Japan using the Structured Clinical Interview for DSM-IV
por: Tomita T, et al.
Publicado: (2016)

Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations
por: Mayerova M, et al.
Publicado: (2018)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)

Efficacy of atropine combined with paroxetine in vagus nerve excitatory panic disorder
por: Du N, et al.
Publicado: (2015)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga K, et al.
Publicado: (2015)

The association between the subjective memory complaints scale and depressive state and cognitive impairment: a factor analysis
por: Tomita T, et al.
Publicado: (2015)

Interaction between paliperidone extended release and TS-1&reg;, an oral anticancer drug containing a 5-fluorouracil derivative, in a schizophrenic patient
por: Yasui-Furukori N, et al.
Publicado: (2013)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima K, et al.
Publicado: (2013)

Levodopa-responsive depression associated with corticobasal degeneration: a case report
por: Tarakita N, et al.
Publicado: (2017)

Laxative use and clinical correlates in hospitalized patients with obsessive-compulsive disorder: a retrospective descriptive study
por: Lai JB, et al.
Publicado: (2018)

Plasma concentrations and dosing of 2 long-acting injectable formulations of aripiprazole
por: Salzman PM, et al.
Publicado: (2017)

The Effect of Oral L-cysteine on Breast Milk and Plasma Cysteine Concentrations
por: Dowlati Y, et al.
Publicado: (2020)

Suicide in Older Adult Men Is Not Related to a Personal History of Participation in Football
por: Grant L. Iverson, et al.
Publicado: (2021)

Paroxetine ameliorates changes in hippocampal energy metabolism in chronic mild stress-exposed rats
por: Khedr LH, et al.
Publicado: (2015)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression [Corrigendum]
por: Kamijima K, et al.
Publicado: (2013)

Serotonin syndrome induced by the readministration of escitalopram after a short-term interruption in an elderly woman with depression: a case report
por: Sato Y, et al.
Publicado: (2015)

Trazodone effects on [3H]-paroxetine and &alpha;2-adrenoreceptors in platelets of patients with major depression
por: Donatella Marazziti, et al.
Publicado: (2010)

Encapsulated Escitalopram and Paroxetine Intranasal Co-Administration: In Vitro/In Vivo Evaluation
por: Soraia Silva, et al.
Publicado: (2021)

Different Attitudes of Patients and Psychiatrists Toward Benzodiazepine Treatment
por: Kawamata Y, et al.
Publicado: (2021)

Possible associations between antioxidant enzyme polymorphisms and metabolic abnormalities in patients with schizophrenia
por: Saruwatari J, et al.
Publicado: (2013)

Consensus recommendation on the use of therapeutic plasma exchange for adult neurological diseases in Southeast Asia from the Southeast Asia therapeutic plasma exchange consortium
por: Fu Liong Hiew, et al.
Publicado: (2021)